Please assess the completion status of the following clinical trial:

Trial Title: Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* positive results of both rapid urease test and histology,~* a positive result of urea breath test,~* or a positive result of culture.~Exclusion Criteria:~* ingestion of antibiotics, bismuth, or proton pump inhibitor（PPI）within the prior 4 weeks,~* patients with allergic history to the medications used,~* patients with previous gastric surgery,~* the coexistence of serious concomitant illness (for example, decompensated liver cirrhosis, uremia),~* pregnant women

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- esomeprazole+amox+levo (Type: ACTIVE_COMPARATOR): esomeprazole 40 mg b.d., amoxicillin 500 mg q.d.s., and levofloxacin 500 mg o.d.
- esomeprazole+bismuth+tetra+levo (Type: EXPERIMENTAL): esomeprazole 40 mg b.d., bismuth 120 mg q.d.s., tetracycline 500 mg q.d.s., and levofloxacin 500 mg o.d.

Based on this trial design, predict the completion outcome and termination type (if applicable).